uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 19, 2020

Seller of Thrive "Anti-Viral" Supplements Settles with FTC for Unproven Coronavirus and Cancer Claims

On October 19, 2020, the Federal Trade Commission (FTC) approved an administrative consent order to settle charges that marketer Marc Ching was making unsubstantiated claims that the supplement Thrive can treat, prevent, or reduce the risk of coronavirus (COVID-19). Thrive consists mainly of vitamin C and herbal extracts.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at